Published by LAP LAMBERT Academic Publishing, 2025
ISBN 10: 6208418275 ISBN 13: 9786208418274
Language: English
Seller: California Books, Miami, FL, U.S.A.
Condition: New.
Published by LAP LAMBERT Academic Publishing, 2025
ISBN 10: 6208418275 ISBN 13: 9786208418274
Language: English
Seller: Ria Christie Collections, Uxbridge, United Kingdom
US$ 48.64
Quantity: Over 20 available
Add to basketCondition: New. In.
Published by LAP LAMBERT Academic Publishing, 2025
ISBN 10: 6208418275 ISBN 13: 9786208418274
Language: English
Seller: Books Puddle, New York, NY, U.S.A.
Condition: New.
Published by LAP LAMBERT Academic Publishing Jan 2025, 2025
ISBN 10: 6208418275 ISBN 13: 9786208418274
Language: English
Seller: buchversandmimpf2000, Emtmannsberg, BAYE, Germany
Taschenbuch. Condition: Neu. Neuware -AI and machine learning (ML) are increasingly transforming the field of radiopharmaceutical development, offering new ways to design, optimize, and evaluate these critical compounds. Radiopharmaceuticals, which are used for both diagnostic imaging and targeted therapy, require precise formulation and testing to ensure safety and efficacy. AI and ML technologies can accelerate this process by analyzing vast amounts of complex data, identifying patterns, and making predictions that were previously time-consuming or difficult.Machine learning algorithms, such as deep learning and reinforcement learning, are used to model molecular interactions, predict the behavior of radiopharmaceuticals within the body, and optimize the selection of radioisotopes for specific targeting. AI-driven tools also enable faster drug discovery by simulating and predicting the outcomes of radiopharmaceutical interactions with biological systems, thus reducing the need for extensive trial and error.Books on Demand GmbH, Überseering 33, 22297 Hamburg 60 pp. Englisch.
Published by LAP LAMBERT Academic Publishing, 2025
ISBN 10: 6208418275 ISBN 13: 9786208418274
Language: English
Seller: preigu, Osnabrück, Germany
Taschenbuch. Condition: Neu. AI and Machine Learning in Radiopharmaceutical Development | "From Design to Therapy: The Impact of AI in Radiopharmaceutical Development" | Khushboo Gupta (u. a.) | Taschenbuch | Englisch | 2025 | LAP LAMBERT Academic Publishing | EAN 9786208418274 | Verantwortliche Person für die EU: LAP Lambert Academic Publishing, Brivibas Gatve 197, 1039 RIGA, LETTLAND, customerservice[at]vdm-vsg[dot]de | Anbieter: preigu.
Published by KS Omniscriptum Publishing, 2025
ISBN 10: 6208418275 ISBN 13: 9786208418274
Language: English
Seller: PBShop.store US, Wood Dale, IL, U.S.A.
PAP. Condition: New. New Book. Shipped from UK. THIS BOOK IS PRINTED ON DEMAND. Established seller since 2000.
Published by KS Omniscriptum Publishing, 2025
ISBN 10: 6208418275 ISBN 13: 9786208418274
Language: English
Seller: PBShop.store UK, Fairford, GLOS, United Kingdom
US$ 51.56
Quantity: Over 20 available
Add to basketPAP. Condition: New. New Book. Delivered from our UK warehouse in 4 to 14 business days. THIS BOOK IS PRINTED ON DEMAND. Established seller since 2000.
Published by LAP LAMBERT Academic Publishing Jan 2025, 2025
ISBN 10: 6208418275 ISBN 13: 9786208418274
Language: English
Seller: BuchWeltWeit Ludwig Meier e.K., Bergisch Gladbach, Germany
Taschenbuch. Condition: Neu. This item is printed on demand - it takes 3-4 days longer - Neuware 60 pp. Englisch.
Published by LAP LAMBERT Academic Publishing, 2025
ISBN 10: 6208418275 ISBN 13: 9786208418274
Language: English
Seller: Majestic Books, Hounslow, United Kingdom
Condition: New. Print on Demand.
Published by LAP LAMBERT Academic Publishing, 2025
ISBN 10: 6208418275 ISBN 13: 9786208418274
Language: English
Seller: Biblios, Frankfurt am main, HESSE, Germany
Condition: New. PRINT ON DEMAND.
Published by LAP Lambert Academic Publishing, 2025
ISBN 10: 6208418275 ISBN 13: 9786208418274
Language: English
Seller: CitiRetail, Stevenage, United Kingdom
US$ 57.73
Quantity: 1 available
Add to basketPaperback. Condition: new. Paperback. AI and machine learning (ML) are increasingly transforming the field of radiopharmaceutical development, offering new ways to design, optimize, and evaluate these critical compounds. Radiopharmaceuticals, which are used for both diagnostic imaging and targeted therapy, require precise formulation and testing to ensure safety and efficacy. AI and ML technologies can accelerate this process by analyzing vast amounts of complex data, identifying patterns, and making predictions that were previously time-consuming or difficult.Machine learning algorithms, such as deep learning and reinforcement learning, are used to model molecular interactions, predict the behavior of radiopharmaceuticals within the body, and optimize the selection of radioisotopes for specific targeting. AI-driven tools also enable faster drug discovery by simulating and predicting the outcomes of radiopharmaceutical interactions with biological systems, thus reducing the need for extensive trial and error. This item is printed on demand. Shipping may be from our UK warehouse or from our Australian or US warehouses, depending on stock availability.
Published by LAP LAMBERT Academic Publishing, 2025
ISBN 10: 6208418275 ISBN 13: 9786208418274
Language: English
Seller: AHA-BUCH GmbH, Einbeck, Germany
Taschenbuch. Condition: Neu. nach der Bestellung gedruckt Neuware - Printed after ordering - AI and machine learning (ML) are increasingly transforming the field of radiopharmaceutical development, offering new ways to design, optimize, and evaluate these critical compounds. Radiopharmaceuticals, which are used for both diagnostic imaging and targeted therapy, require precise formulation and testing to ensure safety and efficacy. AI and ML technologies can accelerate this process by analyzing vast amounts of complex data, identifying patterns, and making predictions that were previously time-consuming or difficult.Machine learning algorithms, such as deep learning and reinforcement learning, are used to model molecular interactions, predict the behavior of radiopharmaceuticals within the body, and optimize the selection of radioisotopes for specific targeting. AI-driven tools also enable faster drug discovery by simulating and predicting the outcomes of radiopharmaceutical interactions with biological systems, thus reducing the need for extensive trial and error.